The data suggested that methylated circulating CCDC181, GCM2 and ITPRIPL1 were mostly derived from primary tumors and could serve as new postsurgical monitoring biomarkers for the detection of residual tumors, with the exception of primary breast tumors. Here, GCM2 is linked to breast neoplasm.